UK markets close in 58 minutes

Lyell Immunopharma, Inc. (LYEL)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
1.3350+0.0300 (+2.30%)
As of 10:32AM EDT. Market open.
Show:
Income statement
Cash flow
Annual

Balance sheet

All numbers in thousands
Breakdown
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Assets
Current assets
Cash
Cash and cash equivalents
145,647
123,554
293,828
140,406
-
Other short-term investments
400,576
516,598
320,966
472,213
-
Total cash
546,223
640,152
614,794
612,619
-
Other current assets
8,463
11,143
11,492
4,928
-
Total current assets
554,686
651,295
626,286
617,547
-
Non-current assets
Property, plant and equipment
Gross property, plant and equipment
193,964
198,649
181,152
129,159
-
Accumulated depreciation
-51,647
-32,384
-14,513
-5,104
-
Net property, plant and equipment
142,317
166,265
166,639
124,055
-
Equity and other investments
48,507
115,041
330,532
163,443
-
Other long-term assets
4,519
4,960
3,949
3,235
-
Total non-current assets
195,343
286,266
501,120
290,733
-
Total assets
750,029
937,561
1,127,406
908,280
-
Liabilities and stockholders' equity
Liabilities
Current liabilities
Accounts payable
4,817
3,917
3,207
9,396
-
Accrued liabilities
5,726
6,422
9,123
8,897
-
Deferred revenues
-
0
4,988
6,095
4,511
Other current liabilities
3,069
6,708
10,955
6,430
-
Total current liabilities
34,519
37,028
46,738
49,285
-
Non-current liabilities
Deferred revenues
-
0
79,665
89,066
98,406
Other long-term liabilities
3,664
4,113
4,566
532
-
Total non-current liabilities
60,558
67,281
150,881
140,555
-
Total liabilities
95,077
104,309
197,619
189,840
-
Stockholders' equity
Common stock
25
25
24
1,010,970
-
Retained earnings
-1,002,112
-767,480
-584,362
-334,143
-
Accumulated other comprehensive income
-94
-7,599
-1,623
256
-
Total stockholders' equity
654,952
833,252
929,787
718,440
-
Total liabilities and stockholders' equity
750,029
937,561
1,127,406
908,280
-